• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富马酸二甲酯治疗可诱导脂质代谢改变,这些改变与免疫变化有关。

Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes.

机构信息

Department of Neurology Johns Hopkins University School of Medicine Baltimore Maryland.

出版信息

Ann Clin Transl Neurol. 2018 Oct 30;6(1):33-45. doi: 10.1002/acn3.676. eCollection 2019 Jan.

DOI:10.1002/acn3.676
PMID:30656182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6331509/
Abstract

OBJECTIVE

Identify metabolic changes produced by dimethyl fumarate (DMF) treatment and link them to immunological effects.

METHODS

We enrolled 18 MS patients and obtained blood prior to DMF and 6 months postinitiation. We also enrolled 18 healthy controls for comparison. We performed global metabolomics on plasma and used weighted correlation network analysis (WGCNA) to identify modules of correlated metabolites. We identified modules that changed with treatment, followed by targeted metabolomics to corroborate changes identified in global analyses. We correlated changes in metabolite modules and individual metabolites with changes in immunological parameters.

RESULTS

We identified alterations in lipid metabolism after DMF treatment - increases in two modules (phospholipids, lysophospholipids and plasmalogens) and reduction in one module (saturated and poly-unsaturated fatty acids) eigen-metabolite values (all  < 0.05). Change in the fatty acid module was greater in participants who developed lymphopenia and was strongly associated with both reduction in absolute lymphocyte counts (=0.65;  = 0.005) and change in CD8+ T cell subsets. We also noted significant correlation of change in lymphocyte counts with multiple fatty acid levels (measured by targeted or untargeted methods).

INTERPRETATION

This study demonstrates that DMF treatment alters lipid metabolism and that changes in fatty acid levels are related to DMF-induced immunological changes.

摘要

目的

鉴定富马酸二甲酯(DMF)治疗引起的代谢变化,并将其与免疫作用联系起来。

方法

我们纳入了 18 名 MS 患者,并在 DMF 治疗前和治疗后 6 个月采集了血液样本。我们还纳入了 18 名健康对照者进行比较。我们对血浆进行了全局代谢组学分析,并使用加权相关网络分析(WGCNA)来鉴定相关代谢物模块。我们鉴定了与治疗相关的变化模块,然后进行靶向代谢组学分析以证实全局分析中鉴定的变化。我们将代谢物模块和个体代谢物的变化与免疫参数的变化相关联。

结果

我们发现 DMF 治疗后脂质代谢发生了改变——两个模块(磷脂、溶血磷脂和血浆类脂)的含量增加,一个模块(饱和脂肪酸和多不饱和脂肪酸)的特征代谢物值降低(均  <0.05)。在发生淋巴细胞减少的参与者中,脂肪酸模块的变化更大,并且与绝对淋巴细胞计数的减少(=0.65;=0.005)和 CD8+T 细胞亚群的变化密切相关。我们还注意到,淋巴细胞计数的变化与多种脂肪酸水平(通过靶向或非靶向方法测量)显著相关。

结论

这项研究表明,DMF 治疗会改变脂质代谢,脂肪酸水平的变化与 DMF 诱导的免疫变化有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/7b4630cdde76/ACN3-6-33-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/7428b9f121f9/ACN3-6-33-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/01f7a1159e1e/ACN3-6-33-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/c0ff151fd761/ACN3-6-33-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/7b4630cdde76/ACN3-6-33-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/7428b9f121f9/ACN3-6-33-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/01f7a1159e1e/ACN3-6-33-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/c0ff151fd761/ACN3-6-33-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6a9/6331509/7b4630cdde76/ACN3-6-33-g004.jpg

相似文献

1
Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes.富马酸二甲酯治疗可诱导脂质代谢改变,这些改变与免疫变化有关。
Ann Clin Transl Neurol. 2018 Oct 30;6(1):33-45. doi: 10.1002/acn3.676. eCollection 2019 Jan.
2
Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.复发缓解型多发性硬化症的特征是滤泡辅助性 T 细胞炎症前偏移,二甲基富马酸酯治疗可使其逆转。
Front Immunol. 2018 May 29;9:1097. doi: 10.3389/fimmu.2018.01097. eCollection 2018.
3
Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.富马酸二甲酯诱导 B 淋巴细胞和 T 淋巴细胞功能改变,与淋巴细胞绝对计数无关。
Mult Scler. 2018 May;24(6):728-738. doi: 10.1177/1352458517707069. Epub 2017 May 8.
4
Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.来氟米特治疗复发性缓解型多发性硬化症患者发生淋巴细胞减少症的危险因素。
J Neurol. 2020 Jan;267(1):125-131. doi: 10.1007/s00415-019-09557-w. Epub 2019 Oct 3.
5
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.富马酸二甲酯治疗介导多发性硬化症患者B细胞亚群的抗炎转变。
J Immunol. 2017 Jan 15;198(2):691-698. doi: 10.4049/jimmunol.1601649. Epub 2016 Dec 14.
6
Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.富马酸二甲酯选择性减少多发性硬化症患者的记忆性T细胞并改变Th1/Th17和Th2之间的平衡。
J Immunol. 2017 Apr 15;198(8):3069-3080. doi: 10.4049/jimmunol.1601532. Epub 2017 Mar 3.
7
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension.在复发缓解型多发性硬化症的日本患者中,二甲基富马酸的 72 周安全性和耐受性:随机、双盲、安慰剂对照、III 期 APEX 研究及其开放标签扩展的分析。
Adv Ther. 2018 Oct;35(10):1598-1611. doi: 10.1007/s12325-018-0788-8. Epub 2018 Sep 11.
8
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis.预测多发性硬化症患者用二甲基富马酸诱导淋巴细胞减少后淋巴细胞计数恢复的因素。
J Neurol. 2021 Jun;268(6):2238-2245. doi: 10.1007/s00415-021-10412-0. Epub 2021 Jan 26.
9
Effects of dimethyl fumarate on lymphocyte subsets.富马酸二甲酯对淋巴细胞亚群的影响。
Mult Scler Relat Disord. 2015 Jul;4(4):339-41. doi: 10.1016/j.msard.2015.06.002. Epub 2015 Jun 10.
10
Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia.应用药物基因组学研究多发性硬化症疾病改善治疗的药物不良反应:富马酸二甲酯诱导淋巴细胞减少的病例对照研究方案
BMJ Open. 2017 Jun 2;7(5):e016276. doi: 10.1136/bmjopen-2017-016276.

引用本文的文献

1
Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel disease.NRF2激活药物RTA-408在抑制T细胞效应反应和炎症性肠病方面的治疗潜力。
J Immunol. 2025 Aug 1;214(8):1951-1968. doi: 10.1093/jimmun/vkaf117.
2
Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy.重新利用的Nrf2激活剂富马酸二甲酯可挽救杜氏肌营养不良症加重型mdx小鼠模型中的肌肉炎症和纤维化。
Redox Biol. 2025 Jul;84:103676. doi: 10.1016/j.redox.2025.103676. Epub 2025 May 14.
3
Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2.

本文引用的文献

1
Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.富马酸二甲酯通过靶向 GAPDH 和有氧糖酵解来调节免疫。
Science. 2018 Apr 27;360(6387):449-453. doi: 10.1126/science.aan4665. Epub 2018 Mar 29.
2
Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.富马酸二甲酯治疗改变多发性硬化症患者 NK 细胞功能。
Eur J Immunol. 2018 Feb;48(2):380-383. doi: 10.1002/eji.201747277. Epub 2017 Dec 15.
3
Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior.
饮食可调节由免疫代谢中性粒细胞受体HCAR2介导的富马酸二甲酯的治疗效果。
Elife. 2025 Apr 23;14:e98970. doi: 10.7554/eLife.98970.
4
RNA N4-acetylcytidine modification and its role in health and diseases.RNA N4-乙酰胞苷修饰及其在健康与疾病中的作用。
MedComm (2020). 2025 Jan 3;6(1):e70015. doi: 10.1002/mco2.70015. eCollection 2025 Jan.
5
Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast Cancer.内分泌抵抗性雌激素受体阳性乳腺癌中的代谢转换
bioRxiv. 2024 Dec 29:2024.12.28.630631. doi: 10.1101/2024.12.28.630631.
6
Ocrelizumab alters the circulating metabolome in people with relapsing-remitting multiple sclerosis.奥瑞珠单抗改变了复发缓解型多发性硬化症患者的循环代谢组。
Ann Clin Transl Neurol. 2024 Sep;11(9):2485-2498. doi: 10.1002/acn3.52167. Epub 2024 Aug 26.
7
N4-acetylcytidine modifies primary microRNAs for processing in cancer cells.N4-乙酰胞苷可修饰癌症细胞中的初级 microRNA 进行加工。
Cell Mol Life Sci. 2024 Feb 3;81(1):73. doi: 10.1007/s00018-023-05107-w.
8
Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course.将微生物基因与血浆和粪便代谢物联系起来,揭示了溃疡性结肠炎疾病进程中宿主-微生物相互作用的机制。
Cell Host Microbe. 2024 Feb 14;32(2):209-226.e7. doi: 10.1016/j.chom.2023.12.013. Epub 2024 Jan 11.
9
Metabolite Alterations in Autoimmune Diseases: A Systematic Review of Metabolomics Studies.自身免疫性疾病中的代谢物改变:代谢组学研究的系统综述
Metabolites. 2023 Sep 1;13(9):987. doi: 10.3390/metabo13090987.
10
Dimethyl fumarate modulates the dystrophic disease program following short-term treatment.富马酸二甲酯可在短期治疗后调节进行性肌营养不良症的病变进程。
JCI Insight. 2023 Nov 8;8(21):e165974. doi: 10.1172/jci.insight.165974.
在 PD-1 缺陷小鼠中系统性激活 T 细胞引起的代谢转变扰乱了脑单胺和情绪行为。
Nat Immunol. 2017 Dec;18(12):1342-1352. doi: 10.1038/ni.3867. Epub 2017 Oct 23.
4
Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.多发性硬化症中的代谢改变及维生素 D 补充的影响。
JCI Insight. 2017 Oct 5;2(19):95302. doi: 10.1172/jci.insight.95302.
5
Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.对于来氟米特治疗多发性硬化症的最佳反应与从炎症细胞特征向耐受原性血细胞特征的转变有关。
Mult Scler. 2018 Sep;24(10):1317-1327. doi: 10.1177/1352458517717088. Epub 2017 Jun 27.
6
Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy.烟酸受体、羟基羧酸受体2中的基因编码变体以及对烟酸治疗的反应。
Pharmacogenet Genomics. 2017 Aug;27(8):285-293. doi: 10.1097/FPC.0000000000000289.
7
Dimethyl fumarate alters B-cell memory and cytokine production in MS patients.富马酸二甲酯改变多发性硬化症患者的B细胞记忆和细胞因子产生。
Ann Clin Transl Neurol. 2017 Apr 17;4(5):351-355. doi: 10.1002/acn3.411. eCollection 2017 May.
8
Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.二甲基富马酸治疗反应的特点是 MS 患者 CD8+T 细胞不成比例减少。
Mult Scler. 2018 Apr;24(5):632-641. doi: 10.1177/1352458517703799. Epub 2017 Apr 24.
9
Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.血清能量代谢紊乱化合物与多发性硬化症的残疾、病程和神经影像学有关。
Mol Neurobiol. 2017 Nov;54(9):7520-7533. doi: 10.1007/s12035-016-0257-9. Epub 2016 Nov 8.
10
Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma.鞘氨醇激酶-1的下调通过促进黑色素瘤中的M1巨噬细胞反应诱导保护性肿瘤免疫。
Oncotarget. 2016 Nov 1;7(44):71873-71886. doi: 10.18632/oncotarget.12380.